Additional genetic testing was recommended, which revealed compound heterozygous variants in trans in ATM (encoding ataxia telangiectasia mutated, ATM), consistent with a diagnosis of ataxia telangiectasia (AT), a syndrome associated with neurological defects, immunodeficiency, and cancer predisposition. This evidence concerns the gene ATM and Ataxia-telangiectasia.